What is OBSOLETE: Toxic or/and iatrogenic neuropathy?
Toxic or iatrogenic neuropathy refers to nerve damage (neuropathy) that is caused by exposure to harmful substances (toxic neuropathy) or as a side effect of medical treatments such as medications or procedures (iatrogenic neuropathy). This is not a genetic or inherited condition — it is an acquired form of nerve damage. The peripheral nerves, which carry signals between the brain, spinal cord, and the rest of the body, become injured by chemicals, drugs, or other external agents. Common causes include chemotherapy drugs (such as vincristine, cisplatin, or taxanes), certain antibiotics, anti-seizure medications, heavy metals (lead, mercury, arsenic), industrial chemicals, and excessive alcohol use. Symptoms typically begin in the hands and feet and may include numbness, tingling, burning pain, muscle weakness, and difficulty with balance or coordination. The severity depends on the type and duration of exposure. In many cases, symptoms may improve or resolve once the offending substance is removed, though some patients experience lasting nerve damage. Note: This Orphanet entry (206619) is marked as OBSOLETE, meaning it has been retired or reclassified in the Orphanet database. Patients with this condition should look under more specific diagnostic categories for toxic neuropathies or drug-induced neuropathies. Treatment focuses on identifying and removing the causative agent, managing pain, and supporting nerve recovery through rehabilitation. There is no single cure, but early recognition and intervention can significantly improve outcomes.
Key symptoms:
Numbness in hands and feetTingling or pins-and-needles sensationBurning pain in the extremitiesMuscle weaknessDifficulty with balance and coordinationSensitivity to touchCramping or muscle twitchingLoss of reflexesDifficulty walkingDropping objects due to hand weaknessFeeling of wearing invisible gloves or socksDigestive problems such as constipation or diarrheaDizziness or lightheadedness when standing
- Inheritance
- Sporadic
- Usually appears on its own, not inherited from a parent
- Age of Onset
- Variable
- Can begin at different ages, from infancy through adulthood
Treatments
Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly
No FDA-approved treatments are currently listed for OBSOLETE: Toxic or/and iatrogenic neuropathy.
View clinical trials →Clinical Trials
View all trials with filters →Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest
No actively recruiting trials found for OBSOLETE: Toxic or/and iatrogenic neuropathy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)
No specialists are currently listed for OBSOLETE: Toxic or/and iatrogenic neuropathy.
Treatment Centers
8 centersSource: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months
Children's Hospital Colorado Rare Disease Program ↗
Children's Hospital Colorado
📍 Aurora, CO
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDBoston Children's Hospital Rare Disease Program ↗
Boston Children's Hospital
📍 Boston, MA
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
🏨 Children'sAnn & Robert H. Lurie Children's Hospital Genetics ↗
Lurie Children's Hospital
📍 Chicago, IL
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDCincinnati Children's Hospital Medical Center ↗
Cincinnati Children's
📍 Cincinnati, OH
👤 Boston Children's Hospital Rare Disease Program
🏨 Children'sNationwide Children's Hospital Rare Disease Center ↗
Nationwide Children's Hospital
📍 Columbus, OH
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Travel Grants
No travel grants are currently matched to OBSOLETE: Toxic or/and iatrogenic neuropathy.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Toxic or/and iatrogenic neuropathy.
Start the conversation →Latest news about OBSOLETE: Toxic or/and iatrogenic neuropathy
Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC
No recent news articles for OBSOLETE: Toxic or/and iatrogenic neuropathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the most likely cause of my neuropathy, and can it be removed or reduced?,Will my nerve damage improve over time, or is it likely to be permanent?,What medications or therapies can help manage my pain and other symptoms?,Should I see a neurologist or pain specialist for ongoing management?,Are there any medications I should avoid that could worsen my nerve damage?,What physical therapy or rehabilitation options would benefit me?,How often should I have follow-up nerve conduction studies to monitor my condition?
Common questions about OBSOLETE: Toxic or/and iatrogenic neuropathy
What is OBSOLETE: Toxic or/and iatrogenic neuropathy?
Toxic or iatrogenic neuropathy refers to nerve damage (neuropathy) that is caused by exposure to harmful substances (toxic neuropathy) or as a side effect of medical treatments such as medications or procedures (iatrogenic neuropathy). This is not a genetic or inherited condition — it is an acquired form of nerve damage. The peripheral nerves, which carry signals between the brain, spinal cord, and the rest of the body, become injured by chemicals, drugs, or other external agents. Common causes include chemotherapy drugs (such as vincristine, cisplatin, or taxanes), certain antibiotics, anti-s
How is OBSOLETE: Toxic or/and iatrogenic neuropathy inherited?
OBSOLETE: Toxic or/and iatrogenic neuropathy follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Frequently asked questions about OBSOLETE: Toxic or/and iatrogenic neuropathy
Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.
What is OBSOLETE: Toxic or/and iatrogenic neuropathy?
OBSOLETE: Toxic or/and iatrogenic neuropathy is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:206619). It is typically inherited as sporadic. Age of onset is generally variable. For verified primary sources, see the UniteRare OBSOLETE: Toxic or/and iatrogenic neuropathy page.
How is OBSOLETE: Toxic or/and iatrogenic neuropathy inherited?
OBSOLETE: Toxic or/and iatrogenic neuropathy follows sporadic inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.
Are there FDA-approved treatments for OBSOLETE: Toxic or/and iatrogenic neuropathy?
Approved treatments for OBSOLETE: Toxic or/and iatrogenic neuropathy are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.
Are there clinical trials for OBSOLETE: Toxic or/and iatrogenic neuropathy?
Active clinical trials for OBSOLETE: Toxic or/and iatrogenic neuropathy are tracked daily from ClinicalTrials.gov. Trial availability changes frequently; check the UniteRare trial listings for the current count and recruitment status. Sponsors of rare-disease research often welcome inquiries even when a trial is not actively recruiting at a given moment.
How do I find a specialist for OBSOLETE: Toxic or/and iatrogenic neuropathy?
Verified OBSOLETE: Toxic or/and iatrogenic neuropathy specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.
See full OBSOLETE: Toxic or/and iatrogenic neuropathy page for complete clinical details, sources, and verified-specialist listings.
Cite this page
Select a citation format above to view and copy.